Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model
Open Access
- 25 August 2023
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (9) , 7097-7109
Abstract
Nicotinamide riboside (NR), a precursor of nicotinamide adenine dinucleotide (NAD+), has been studied to support human health against metabolic stress, cardiovascular disease, and neurodegenerative disease. In the present study, we investigated the effects of oral NR on axonal damage in a rat ocular hypertension model. Intraocular pressure (IOP) elevation was induced by laser irradiation and then the rats received oral NR of 1000 mg/kg/day daily. IOP elevation was seen 7, 14, and 21 days after laser irradiation compared with the controls. We confirmed that oral NR administration significantly increased NAD+ levels in the retina. After 3-week oral administration of NR, morphometric analysis of optic nerve cross-sections showed that the number of axons was protected compared with that in the untreated ocular hypertension group. Oral NR administration significantly prevented retinal ganglion cell (RGC) fiber loss in retinal flat mounts, as shown by neurofilament immunostaining. Immunoblotting samples from the optic nerves showed that oral NR administration augmented the phosphorylated adenosine monophosphate-activated protein kinase (p-AMPK) level in rats with and without ocular hypertension induction. Immunohistochemical analysis showed that some p-AMPK-immunopositive fibers were colocalized with neurofilament immunoreactivity in the control group, and oral NR administration enhanced p-AMPK immunopositivity. Our findings suggest that oral NR administration protects against glaucomatous RGC axonal degeneration with the possible upregulation of p-AMPK.Keywords
Funding Information
- KAKENHI (22K09843, 23K15944, 22K20981)
This publication has 40 references indexed in Scilit:
- AMPK activation protects cells from oxidative stress‐induced senescence via autophagic flux restoration and intracellular NAD + elevationAging Cell, 2016
- Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes MellitusJAMA Ophthalmology, 2015
- Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagyBritish Journal of Pharmacology, 2014
- Axonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degenerationCell Death & Disease, 2013
- Effects of Metformin in Experimental StrokeStroke, 2010
- Axonal and Cell Body Protection By Nicotinamide Adenine Dinucleotide in Tumor Necrosis Factor-Induced Optic NeuropathyJournal of Neuropathology & Experimental Neurology, 2009
- Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucomaJournal of Cell Biology, 2007
- Stimulation of Nicotinamide Adenine Dinucleotide Biosynthetic Pathways Delays Axonal Degeneration after AxotomyJournal of Neuroscience, 2006
- Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J miceJournal of Cell Biology, 2005
- ParaphenylenediamineJournal of Neuropathology & Experimental Neurology, 1983